AXIS-2: G-CSF Fails to Improve Recovery After StrokeAXIS-2: G-CSF Fails to Improve Recovery After Stroke
AX200, a novel neuroprotectant, was no better than placebo in improving functional outcomes in phase 2 testing. Medscape Medical News (Source: Medscape Today Headlines)
Well Blog: A Better Way to Spend Breast Cancer Funds?
We must move breast cancer advocacy to the next level, beyond screening for cancers that are already there, even beyond the cure, to finding the cause, writes Dr. Susan Love. (Source: NYT Health)
